The Global CEO Initiative on Alzheimer’s Disease Publishes the First Performance Recommendations for Blood-Based Biomarker Tests by Experts in the Field
June 12, 2024 09:10 ET
|
The Global CEO Initiative on Alzheimer's Disease
Philadelphia, Pennsylvania, June 12, 2024 (GLOBE NEWSWIRE) -- The Global CEO Initiative on Alzheimer’s Disease (CEOi), convened by UsAgainstAlzheimer’s, is proud to announce the peer-reviewed...
![The Global CEO Initiative on Alzheimer's Disease Logo](/news-release/logo/333043/0/333043.jpg?lastModified=12%2F09%2F2016%2022%3A58%3A33&size=2)
Global Leaders in Dementia Meet to Stop Alzheimer's by 2025
December 17, 2015 14:36 ET
|
The Global CEO Initiative on Alzheimer's Disease
LAUSANNE, Switzerland, Dec. 17, 2015 (GLOBE NEWSWIRE) -- On December 15-16, experts convened in Lausanne to define an action plan to speed effective treatments and diagnostics for Alzheimer's disease...
![The Global CEO Initiative on Alzheimer's Disease Logo](/news-release/logo/333043/0/333043.jpg?lastModified=12%2F09%2F2016%2022%3A58%3A33&size=2)
Axovant Sciences Joins the Global CEO Initiative on Alzheimer's Disease
October 13, 2015 11:54 ET
|
The Global CEO Initiative on Alzheimer's Disease
WASHINGTON, Oct. 13, 2015 (GLOBE NEWSWIRE) -- The Global CEO Initiative on Alzheimer's Disease (CEOi) today announced that Axovant Sciences will join the CEOi as part of its ongoing effort to advance...
![The Global CEO Initiative on Alzheimer's Disease Logo](/news-release/logo/333043/0/333043.jpg?lastModified=12%2F09%2F2016%2022%3A58%3A33&size=2)
GAP and IMI to Sign MOU to Accelerate Alzheimer's Drug Development
March 19, 2015 09:57 ET
|
The Global CEO Initiative on Alzheimer's Disease
WASHINGTON and NICE, FRANCE, March 19, 2015 (GLOBE NEWSWIRE) -- The Global Alzheimer's Platform (GAP) and the Innovative Medicines Initiative (IMI) announced today that they will sign a Memorandum of...
![The Global CEO Initiative on Alzheimer's Disease Logo](/news-release/logo/333043/0/333043.jpg?lastModified=12%2F09%2F2016%2022%3A58%3A33&size=2)
Global CEO Initiative on Alzheimer's Disease (CEOi) Launches Program to Harness Power of Big Data, Accelerating Pace of Alzheimer's Research
February 25, 2015 09:46 ET
|
The Global CEO Initiative on Alzheimer's Disease
WASHINGTON, Feb. 25, 2015 (GLOBE NEWSWIRE) -- The Global CEO Initiative on Alzheimer's Disease (CEOi) has developed an innovative research initiative with the potential to bring new evidence and...